Enhancing oral drug delivery: Exploring multiparticulate systems
Supported by:
14 August 2024
2:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Explores the benefits and uses of multiparticulate systems in oral drug delivery and how they can help address challenges faced by traditional dosage forms.
Register now to secure your place on this upcoming webinar
This webinar delves into the intricacies of multiparticulate systems, exploring their design, benefits, and the issues they are uniquely positioned to solve, particularly for oral drug delivery.
Multiparticulate systems are advanced drug delivery mechanisms that consist of small discrete units, such as pellets/beads and mini tablets, encapsulated or packaged within a single dosage form.
During this webinar our experts will share:
- What type and form exists and when to consider using multiparticulate systems
- The main advantages of multiparticulate systems for oral drug delivery, such as controlled and targeted drug release, fixed dose combinations, enhanced bioavailability, dosage flexibility and others.
- How these systems can help solve challenges of orally delivered drugs, such as uniformity, stability, manufacturing complexity and patient compliance.
The webinar will provide case studies illustrating applications of multiparticulate systems and will conclude with a Q&A session, providing an opportunity for attendees to engage with experts in the field.
Who should you attend:
- Pharmaceutical and biopharmaceutical companies looking to enhance their oral drug delivery processes
- Individuals working in formulation development
- Pharmaceutical and biopharmaceutical companies with products transitioning from discovery to clinical development or in clinical development
- Pharma/biopharma/biotech companies with small molecules drug candidates or small molecules in development.
Interested? Complete your details now!
OUR SPEAKER
Ramesh Muttavarapu, MSc, MBA – Technical and Scientific Affairs, Thermo Fisher Scientific, Inc.
Ramesh has more than 20 years of experience in developing and commercialising oral solid dosage forms. His expertise includes formulating dosage forms with mini tablets with tailored drug release profiles and multiparticulates and he has developed and commercialised a variety of products and is co-inventor of a patent on delayed release pellets.
He holds a Bachelors and Masters in pharmaceutics from the University of Bangalore and University of Annamalai, India, respectively. He, he earned an MBA from Linder College of Business, University of Cincinnati, OH, USA.
FAQs
FAQs
Is the webinar free?
Yes – there is no charge to watch the webinar, either live or on-demand.
When will the webinar take place?
14 August 2024 at 3.00pm GMT.
Can I watch it later?
The webinar will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speaker your questions, which will be answered live in the Q&A towards the end of the session.
How long will the webinar be?
This webinar will last up to an hour.
What do I need to watch this webinar?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
